Summary:
The primary purpose of the study to evaluate the safety and tolerability of the investigational drug, recombinant herpes zoster vaccine (LZ901), in healthy people and measure levels of specific antibodies in your blood before and after vaccination.
VOLUNTEERS MUST BE:
Ø Healthy male and female participants
Ø 50 - 70 years old
Ø Non-smokers
Qualified Participants May Receive:
Compensation up to 3,600 for your time and travel.